This new approval is one more milestone for Zydus Group, which has now received 420 USFDA approvals. As of now, the company has made 483 Abbreviated New Drug Applications (ANDAs), having started its ...

Zydus Lifesciences Group so far has filed 483 ANDAs and holds 420 approvals since the commencement of the filing process in FY 2003-04. The company reported a net profit of ₹1,023 Crore in the ...

Zydus Group | Photo Credit: Srikrishnan P C@Chennai Zydus Lifesciences Limited (“Zydus”) has entered into exclusive negotiations to purchase a controlling 85.6 percent stake in France-based ...

Zydus Lifesciences will acquire a majority stake in Amplitude Surgical, a European MedTech leader in lower-limb orthopaedic ...

Interetingly, on the other hand, the shares of another listed company from the Zydus group witnessed a surge in its prices. In the opening hours of the day's trade, the shares of Zydus Wellness ...

VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives. The Quadrivalent Inactivated Influenza vaccine has been developed at the Vaccine Technology Centre ...

Tata Communications, Signature Global, Power Grid, GR Infraprojects, Welspun Specialty, and Kolte Patil are among the top ...

in Ahmedabad and is being marketed by Zydus Vaxxicare - a division of the group focussing on preventives. “A quadrivalent vaccine, by covering strains of both influenza A and influenza B ...

Zydus Lifesciences share price extended the gains ... the company informed that the USFDA conducted a surveillance inspection at the group’s API Unit 1, located at Ankleshwar in Gujarat.

Wondering how the vaccine works? Here's all you need to know. Zydus Cadila will seek nod for ZyCoV-D trial on 3-12 age group within 10 days: MD Sharvil Patel When asked about side effects of the ...

Zydus MedTech is focusing on high quality products ... Olivier Jallabert of a portion of his proceeds into the Amplitude group, as well as the absence of qualified material adverse events.